<unk>  is a monoclonal antibody that is FDA approved for the treatment of adults with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH), and for adults and children 1 month of age and older with a disease called atypical hemolytic uremic syndrome (aHUS). ULTOMIRIS is only available through a program called the ULTOMIRIS REMS. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include respiratory tract infection, headache, diarrhea and fever
ULTOMIRIS is a prescription medicine called a monoclonal antibody..
Ravulizumab
Palivizumab
Motavizumab
Mogamulizumab
Natalizumab
Risankizumab
Tildrakizumab
Tocilizumab